// App-Quantinova.ai

e21605 : Study of patient risk factors for febrile neutropenia in non-Hodgkin lymphoma receiving R-CHOP regimen: STOP FN single institution analysis in Japan.

Researchers

Presenter

  • Masahiro Yokoyama

Principal Investigators

  • Yoshiharu Kusano

  • Anna Takahashi

  • Norihito Inoue

  • Tadahiro Gunji

  • Hideaki Nitta

  • Kyoko Ueda

  • Noriko Nishimura

  • Yuko Mishima

  • Yasuhito Terui

  • Kiyohiko Hatake

Medical Centers

  • Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan

  • Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan

  • Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non-Hodgkin's Lymphoma

  • Neutropenia

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • B-lymphocyte antigen CD20

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • UMIN000015121

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved